Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers
International Journal of Molecular Sciences · 03.08.2026 · 27 (15) · 6969
DOI: 10.3390/ijms27156969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.08.2026. Verfasst von Hyun-Jong Jang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Artificial Intelligence, Gastrointestinal Neoplasms, Liver Neoplasms. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Artificial intelligence (AI) has emerged as a promising tool for inferring molecular biomarkers directly from digitized histopathologic slides. However, the current evidence in gastrointestinal and hepatobiliary cancers remains fragmented across tumor types and biomarker categories. Relevant studies were systematically identified and screened according to the PRISMA 2020 statement. PubMed, Embase, Web of Science Core Collection, Scopus, and IEEE Xplore were searched from 1 January 2015 to the date of search. Eligible studies involved gastrointestinal or hepatobiliary malignancies, used histopathology images, applied AI-based methods, and reported molecular biomarker prediction or inference. A total of 110 studies were included. Most studies focused on colorectal, gastric, liver, and pancreatic cancers, with microsatellite instability, mutation status, molecular subtypes, and tumor mutational burden being the most commonly investigated targets. Model architectures evolved from conventional convolutional neural networks to multiple-instance learning and transformer-based methods. While many studies reported promising predictive performance, direct comparison across studies remained challenging because of substantial heterogeneity in datasets, model architectures, and validation strategies. AI-based molecular biomarker identification from pathologic slides shows substantial promise in gastrointestinal and hepatobiliary cancers, but current evidence is constrained by heterogeneity and limited validation. Standardized, multicenter studies are needed before routine clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu 11765, Republic of Korea.
- Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Hyun-Jong Jang, Kwangil Yim, Sung Hak Lee
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jang, H. J., Yim, K., & Lee, S. H. (2026). Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers. International Journal of Molecular Sciences, 27(15), 6969. https://doi.org/10.3390/ijms27156969
Vancouver
Jang HJ, Yim K, Lee SH. Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers. International Journal of Molecular Sciences. 2026;27(15):6969. doi:10.3390/ijms27156969
BibTeX
@article{Jang2026,
author = {Jang, Hyun-Jong and Yim, Kwangil and Lee, Sung Hak},
title = {Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6969},
doi = {10.3390/ijms27156969}
}
EUVIMED